Utama › Kanser (semua jenis) › Georgia › Atlanta
Kajian klinikal Kanser (semua jenis) di Atlanta, GA
49 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Atlanta (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Mengambil pesertaFasa 3
- Emory Winship Cancer Institute, Atlanta
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- Emory University Medical Center, Atlanta
Registry Study for Radiation Therapy Outcomes
Mengambil pesertaKajian pemerhatian
- Emory Proton Therapy Center, Atlanta
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- Emory University, Atlanta
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- Piedmont Physician Medical Oncology Atlanta, Atlanta
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Cancer Treatment Centers of America - Atlanta, Atlanta
- Emory University Winship Cancer Institute, Atlanta
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- Winship Cancer Institute of Emory University, Atlanta
- Northside Hospital, Inc, Atlanta
Connect for Cancer Prevention Study (Connect)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Kaiser Permanente Georgia, Atlanta
Collection of Tissue Samples for Cancer Research
Mengambil pesertaKajian pemerhatian
- Emory University, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- Winship Cancer Institute - Emory University, Atlanta
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
- Emory University, Atlanta
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- Morehouse, Atlanta
- Piedmont Healthcare, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- Winship Cancer Institute of Emory University, Atlanta
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- Emory University, Atlanta
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Emory University Hospital, Atlanta
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Mengambil pesertaFasa 1
- Emory Winship Cancer Institute, Atlanta
Screening Strategies Among High-risk Populations for Anal Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Grady Memorial Hospital, Atlanta
- The Ponce Center, Atlanta
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Mengambil pesertaFasa 3
- Urology of Greater Atlanta - Sandy Springs, Atlanta
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Mengambil pesertaFasa 1/2
- Winship Cancer Institute of Emory University, Atlanta
Safety of Anal Curcumin
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Grady Memorial Hospital, Atlanta
- Grady Hospital - Ponce De Leon Clinic, Atlanta
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- Children's Healthcare of Atlanta, Inc. at Egleston, Atlanta
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- dan 3 lagi
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Mengambil pesertaFasa 2
- Children's Healthcare of Atlanta, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Mengambil pesertaFasa 1/2
- Winship Cancer Institute - Emory University, Atlanta
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Mengambil pesertaFasa 1/2
- Winship Cancer Institute of Emory University /ID# 274830, Atlanta
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Winship Cancer Center - Emory University, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Multi Center Study of Sexual Toxicities After Radiotherapy
Mengambil pesertaKajian pemerhatian
- Emory University, Atlanta
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Emory University/Children's Health Care of Atlanta, Atlanta
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi jauh
Galleri® in the Medicare Population.
Mengambil pesertaSukarelawan sihat dialu-alukan
- Morehouse School of Medicine Atlanta, Atlanta
- Morehouse School of Medicine Lee Street, Atlanta
- Morehouse School of Medicine Princeton Lakes, Atlanta
- dan 1 lagi
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Mengambil pesertaFasa 1/2
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Mengambil pesertaFasa 1
- Winship Cancer Institute at Emory University, Atlanta
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Mengambil peserta
- Children's Hospital of Atlanta, Atlanta
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- Winship Cancer Institute of Emory University, Atlanta
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- Winship Cancer Institute, Emory University, Atlanta
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Mengambil pesertaKajian pemerhatian
- Morehouse, Atlanta
- Piedmont Healthcare, Atlanta
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Mengambil pesertaFasa 2
- Winship Cancer Institute of Emory University /ID# 230643, Atlanta
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Morehouse School of Medicine (MSM), Atlanta
- Piedmont Healthcare, Atlanta
Caris Biorepository Research Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Emory University, Atlanta
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Mengambil pesertaKajian pemerhatian
- Emory University School of Medicine, Atlanta
Childhood Cancer Predisposition Study (CCPS)
Mengambil pesertaKajian pemerhatian
- Children's Healthcare of Atlanta (CHOA), Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
Mengambil pesertaFasa 1/2
- Emory - Winship Cancer Institute, Atlanta
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Emory University Hospital Midtown, Atlanta
- Emory University, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- dan 2 lagi
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Mengambil pesertaFasa 1
- Northside Hospital, Atlanta
Morehouse Total Cancer Care Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Morehouse School of Medicine, Atlanta
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY109 kajian
- Boston, MA85 kajian
- Los Angeles, CA74 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Washington, DC58 kajian
- Durham, NC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Arlington, VA48 kajian
- St. Louis, MO46 kajian
Kajian lain di Atlanta
- Kanser Paru-paru Bukan Sel Kecil47 kajian
- Mieloma Pelbagai42 kajian
- Kanser Payudara41 kajian
- Kanser Prostat33 kajian
- Leukemia Mieloid Akut31 kajian
- Kanser Ovari29 kajian
- Kanser Kolorektal29 kajian
- Kanser Paru-paru29 kajian
- Kanser Metastatik28 kajian
- Gangguan Depresi Major25 kajian
- Kegagalan Jantung25 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.